Genetic blueprint of tumors may guide smarter cancer treatment
NCT ID NCT07713550
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study looks at whether detailed genetic testing of tumor tissue or blood can help doctors make better treatment decisions for people with advanced solid tumors or primary brain cancers. About 550 participants will have their tumors genetically profiled, and a smaller group without available tissue will have blood-based testing. The goal is to see how often this information leads to a recommended targeted therapy and whether doctors follow those recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- comprehensive genomic profiling (CGP) via tissue or liquid biopsy
- What this could lead to
- If successful, this could show that routine genomic profiling helps doctors choose more effective, personalized treatments for advanced cancers.
- What could go wrong
- This is an observational study, not a treatment trial. It may not prove that profiling improves outcomes, and results may not apply to all cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Klina
RECRUITINGBrasschaat, 2930, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Liège Sart Tilman
RECRUITINGLiège, 4000, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU UCL Namur
RECRUITINGNamur, 5000, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
GHDC
RECRUITINGGilly, 6060, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Imelda
RECRUITINGBonheiden, 2820, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institute Jules Bordet
RECRUITINGAnderlecht, 1070, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jessa Ziekenhuis
RECRUITINGHasselt, 3500, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Les Cliniques Universitaires St Luc
RECRUITINGWoluwe-Saint-Lambert, 1200, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UZ Brussel
RECRUITINGJette, 1090, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UZ Gent
RECRUITINGGhent, 9000, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UZ Leuven
RECRUITINGLeuven, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Universitaire Ziekenhuis Antwerpen
RECRUITINGEdegem, 2650, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
VITAZ
RECRUITINGSint-Niklaas, 9100, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
ZAS
RECRUITINGAntwerp, 2030, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fighting cancer wasting: can diet and exercise make olanzapine work better?
- Could a gene mutation predict immunotherapy success? virtual trial aims to find out
- Experimental shot aims to rev up immune system against advanced cancers
- Sharper radiation boost aims to tackle head and neck cancers that return
- New drug DS1025a takes on advanced solid tumors in first human trial
- Triple-Drug cocktail aims to tackle Hard-to-Treat cancers